|
Beurs gesloten -
Euronext Paris
17:55:00 27-10-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 152,50 EUR | +0,66% |
|
+0,39% | +28,15% |
| 22/10 | Ipsen: beter dan verwacht derde kwartaal overschaduwd door erosie van Somatuline in 2027 en arbitragerisico |  |
| 22/10 | Ipsen S.A. verhoogt financiële prognose voor heel 2026 | CI |
ETF's gepositioneerd op Ipsen
| Naam | Var. 1 jan | Gewicht | Volume | |
|---|---|---|---|---|
 | +10,99% | - | 27 154 M€ | |
| +7,06% | - | 92 M€ | |
| +11,63% | - | 13 M€ | |
| +5,80% | - | 49 M€ | |
| +0,92% | - | 51 M€ | |
| +12,57% | - | 66 M€ | |
| +11,52% | - | 24 432 M€ | |
| +10,13% | - | 75 M€ | |
| +9,73% | - | 67 M€ | |
| +7,92% | - | 6 M€ | |
| +5,82% | - | 1 193 M€ | |
| +7,94% | - | 6 576 M€ | |
| +11,21% | - | 3 469 M€ | |
| +8,83% | - | 5 871 M€ | |
| 0,00% | 4,67% | 8 M€ | |
| +60,37% | 3,96% | 215 M€ | |
| +15,01% | 3,25% | 23 M€ | |
| +17,04% | 1,94% | 31 M€ | |
| +8,58% | 1,94% | 31 M€ | |
| +2,50% | 1,75% | 574 M€ | |
| +12,24% | 1,54% | 18 M€ | |
| +13,18% | 1,52% | 17 M€ | |
| +11,83% | 1,48% | 160 M€ | |
| 0,00% | 1,05% | 208 M€ | |
| 0,00% | 1,05% | 26 M€ | |
| +11,24% | 0,98% | 125 M€ | |
| +10,23% | 0,87% | 730 M€ | |
| +10,47% | 0,83% | 55 M€ | |
| +10,27% | 0,83% | 20 M€ | |
| +25,39% | 0,79% | 1 260 M€ | |
| +14,16% | 0,78% | 103 M€ | |
| +11,04% | 0,59% | 140 M€ | |
| +1,14% | 0,58% | 38 M€ | |
| +9,04% | 0,54% | 51 M€ | |
| +10,19% | 0,53% | 40 M€ | |
| +7,17% | 0,5% | 23 M€ | |
| +10,30% | 0,47% | 937 M€ |
Werknemers
5.535
Sector
Farmaceutische producten
Agenda
Kies jouw editie
Alle financiële informatie op nationaal niveau
